| Hans-Günter Meyer-Thompson | Verschiedenes
EMCDDA. Using the Global Drug Survey for harm reduction
EMCDDA. Using the Global Drug Survey for harm reduction
The data from the Global Drug Survey (GDS) contains invaluable information that can answer key and novel questions related to the epidemiology of psychoactive substance use as well as inform the development of pragmatic harm reduction resources that put people first. This paper looks at the history of the GDS and the range of harm reduction tools that have been created using data from the survey. (EMCDDA, Lissabon, Juni 2022)
https://www.emcdda.europa.eu/publications/insights/web-surveys/using-global-drug-survey-harm-reduction_en